Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Read the details of recent consultations, submissions and decisions at the TGA Consultation hub.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (73)
- Therapeutic goods regulation (18)
- Over the counter (OTC) medicines (14)
- Prescription medicines (13)
- Legislation (10)
- Complementary medicines (9)
- Listed medicines (8)
- Non-prescription medicines (8)
- Advisory bodies and committees (7)
- Labelling and packaging (6)
- Manufacturing (6)
- Medical devices safety (4)
- Advertising (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Medicines safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Artificial Intelligence (AI) (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Shortages (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Please use the filters or search function to help find relevant consultations.
Results for
"[search-keyword]"
Search
240 result(s) found, displaying 51 to 75
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 15-16th March 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
Closed onConsultationClosed: 15 September 2022. Consultation results are now available on the TGA Consultation Hub
-
Closed onConsultationThe Therapeutic Goods Administration (TGA) is seeking feedback on whether or not certain international scientific guidelines should be adopted.
-
Closed onConsultationProposed amendments to the Poisons Standard. Closing date: 27 May 2022
-
Closed onConsultationThis consultation is for applications and delegate initiated proposals to amend the Poisons Standard. The scheduling amendments and any submissions received will be considered at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications to amend the Poisons Standard, following advice sought at the 3-4 November 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications to amend the Poisons Standard, following advice sought at the 3-4 November 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS).
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
Closed onConsultationConsultation seeking feedback on the repurposing of medicines to inform the development of options for Government consideration closed 1 April 2022
-
Closed onConsultationThe TGA is seeking feedback on the updated 'Listed medicines evidence guidelines - How to demonstrate efficacy of listed medicines'. Closing date: 1 April 2022
-
Closed onConsultationThe TGA is seeking feedback on a proposed priority pathway for assessment of certain novel and life-saving biologicals. Closing date: 28 March 2022
-
Closed onConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2022-23 financial year. Closing date: 7 March 2022
-
Closed onConsultationThe TGA is seeking feedback from sponsors on improving their access to medicine adverse event data. Closing date 18 February 2022
-
Closed onConsultationThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted. Closing date: 20 February 2022
-
Closed onConsultationProposed amendments to the Poisons Standard. Closing date: 31 January 2022
-
Closed onConsultationThe TGA is seeking feedback on a proposal to improve patient access to critical medicines in acute-care settings. Closing date: 7 February 2022
-
Closed onConsultationThe TGA is conducting a public consultation on potential options for the regulation of biologicals manufactured in Australia for export only (and not for supply in Australia). Closing date: 20 December 2021
-
Closed onConsultationThe TGA sought feedback on a Discussion paper on potential changes to mandatory reporting of medical device adverse events.
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23 June 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23 June 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
Closed onConsultationThe Australian Government is undertaking a significant program to reform the regulation of therapeutic goods in Australia. As part of the Australian Government Department of Health, the Therapeutic Goods Administration (TGA) regulates therapeutic goods, and is responsible for implementing the Government’s reforms. The TGA has issued this survey as part of the Government’s reform program.
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-24 June 2021 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-24 June 2021 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
Closed onConsultationThe consultation period on changes to the assistive technologies exemption has been extended to 22 October 2021.
This webpage on the TGA website was printed on 21 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/consultation